unknown
Stage
1
Investors
About
Innovacell develops and commercializes autologous cell therapy products targeting incontinence conditions such as fecal and urinary incontinence, using regenerative medicine technologies primarily sourced from its GMP manufacturing facility in Austria.
Explore Innovacell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.